Public Market Listing
1177HKEX
Live quotes, historical charts, and market capitalization for Sino Biopharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(13 total)
13Total Assets
1Approved
6Phase 3 / Filed
6Phase 1–2 / Early
8Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
adalimumab(Humira) | Approved | TNF-alphaMonoclonal antibody | Inflammatory Bowel DiseasePsoriatic ArthritisPsoriasisRheumatoid Arthritis Ulcerative Colitis, Crohn's Disease |
| Phase 3 | CDK2/CDK4/CDK6 · CDK2/4/6/CDK4Small molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | AKT (inhibitor)Small molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | — | Chronic Hepatitis B | |
| Phase 3 | BCMA x CD3Multispecific antibody | Multiple Myeloma | |
| Phase 3 | PDE3/PDE4Small molecule | Chronic Obstructive Pulmonary Disease | |
| Phase 3 | TYK2Small molecule | Inflammatory Bowel DiseasePsoriasis Ulcerative Colitis, Crohn's Disease | |
| Phase 2 | — | Chronic Hepatitis B | |
| Phase 2 | IL-36 receptor (IL-36R)Monoclonal antibody | Psoriasis | |
| Phase 1/2 | — | Chronic Hepatitis B | |
| Phase 1 | GPRC5D x CD3Multispecific antibody | Multiple Myeloma | |
| Phase 1 | ProteasomeSmall molecule | Multiple Myeloma | |
| Phase 1 | Cereblon E3 ubiquitin-ligaseSmall molecule | Multiple Myeloma |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.